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Neuronal activity, astrocytic responses to this activity, and energy homeostasis are linked
together during baseline, conscious conditions, and short-term rapid activation (as occurs
with sensory or motor function). Nervous system energy homeostasis also varies dur-
ing long-term physiological conditions (i.e., development and aging) and with adaptation
to pathological conditions, such as ischemia or low glucose. Neuronal activation requires
increased metabolism (i.e., ATP generation) which leads initially to substrate depletion,
induction of a variety of signals for enhanced astrocytic function, and increased local blood
ﬂow and substrate delivery. Energy generation (particularly in mitochondria) and use dur-
ing ATP hydrolysis also lead to considerable heat generation. The local increases in blood
ﬂow noted following neuronal activation can both enhance local substrate delivery but also
provides a heat sink to help cool the brain and removal of waste by-products. In this review
we highlight the interactions between short-term neuronal activity and energy metabolism
with an emphasis on signals and factors regulating astrocyte function and substrate supply.
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INTRODUCTION
The goal of this review is to summarize the linkage between neu-
rons and astrocytes during both short-termperturbations in activ-
ity and metabolic function and long-term metabolic adaptation.
In addition, we compare where possible observed and predicted
differences in metabolic function between in vivo and in vitro
preparations, since the varying methods of substrate delivery in
these two conditions lead to contrasting tissue measurements in
spite of well preserved neuronal function and activity. In the ﬁrst
section we introduce the responses associated with neuronal acti-
vation, in the second section we describe in more detail a number
of signals critical for communication across the metabolic unit,
and in the third section discuss long-term metabolic homeostasis.
CEREBRAL METABOLIC UNIT
The three critical cellular elements in determining the response
of the brain to physiological events include: (1) neurons, which
determine cerebral physiological activity based on electrical pro-
cessing; (2) astrocytes andother glial cells,whichdirectly cooperate
between blood vessels and neurons for regulation of energy needs
and maintenance of the extracellular environment; and (3) blood
vessels for both delivery of substrate to the brain (i.e., glucose
and oxygen) and removal of by-products, such as CO2 and heat.
These three elements interact for all aspects of metabolic function,
forming a coherent and functional metabolic unit.
BASAL NEURONAL METABOLISM
Neurons are never completely quiescent, with modulation of
action potential ﬁring during speciﬁc brain states. For example,
in the awake or conscious state there is considerable spontaneous
activity,which is progressively decreasedwithdeeper levels of anes-
thesia (Shulman et al., 2009) and increased with focal neuronal
activation such as sensory or motor function. Neuronal and glial
function is crucially dependent on the maintenance of electro-
chemical gradients across cellular membranes. Therefore, even
during the resting state (i.e., conscious but in the absence of spe-
ciﬁc sensory,mental physical activity) a signiﬁcant portion of ATP
is utilized to fuel Na+/K+-ATPase activity to maintain sodium
and potassium gradients (Pellerin and Magistretti, 1994; Chat-
ton et al., 2000; Voutsinos-Porche et al., 2003) and also needed to
maintain neurotransmitter recycling and packaging for synaptic
vesicles, cell signaling pathways in both neurons and astrocytes,
and repair of structural membrane, protein assemblies, and DNA.
In addition, further studies have also revealed the importance of
the speciﬁc compositionof energy substrate pool and its utilization
for controlling of neuronal excitability and maintaining resting
membrane potential (Rheims et al., 2009; Holmgren et al., 2010;
Zilberter et al., 2010; Ivanov and Zilberter, 2011; Mukhtarov et al.,
2011). For example, lactate is utilized more effectively in the pres-
ence of glucose as an oxidative metabolic substrate, to maintain
synaptic function (Ivanov et al., 2011).
Brain primarily utilizes glucose as its main energy source (in
adults) to synthesize ATP (Clarke and Sokoloff, 1999) and 90%
of cerebral ATP production occurs in the mitochondria though
oxidative phosphorylation. Therefore, cerebral metabolic activ-
ity can be evaluated by measuring cerebral metabolic rates of
glucose (CMR glucose) and oxygen (CMRO2) using either [18F]-
ﬂuoro-2-deoxy-d-glucose positron emission tomography (FDG
PET) together with oxygen-15 PET or calibrated blood oxygen
level dependent functional magnetic resonance imaging (BOLD
fMRI) methods, respectively (Davis et al., 1998; Hoge et al., 1999).
Although rates of energy turnover in the alert resting state are
difﬁcult to estimate, metabolic brain activity remains signiﬁcant
during this awake, non-stimulated state (Shulman et al., 2004).
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Several PET and fMRI studies indicate that during the transition
from the“awake state”to deeper levels of general anesthesia (Smith
et al., 2002; Rothman et al., 2003; Shulman et al., 2004) there is a
widespread, substantial decrease in energy demand; this decrease
is larger in magnitude than the increments in energy consumption
noted during activation (Hyder et al., 2001; Shulman et al., 2009).
For example,∼15% increase in metabolic activity over baseline
is observed in conscious humans during tasks to study cognitive
and other neurological functions (Phelps and Mazziotta, 1985;
Grafton et al., 1992; Elman et al., 1999). In contrast, after the
induction of anesthesia brain oxygen and glucose consumption are
reduced by∼40–50% as revealed by PET measurements; these val-
ues decline further to∼15–20% of baseline upon reaching deeper
levels of anesthesia with pentobarbital (Shulman et al., 2009). Sim-
ilarly, results from 31P magnetic resonance spectroscopy (MRS)
studies, combined with magnetization transfer method to mea-
sure the rate of Pinorganic conversion to ATP, determined that
the progressive decline of ATP metabolism with increasing lev-
els of anesthesia was parallel to the decline in brain EEG activity;
at an isoelectric state the oxidative production rate of ATP was
reduced to 50% compared to light isoﬂurane anesthesia con-
dition (Du et al., 2008). Thus, the conscious state provides a
baseline for activation but also represents a high level of sponta-
neousneural activity andaccompanyingmetabolic demand,which
can be substantially reduced with progressively deeper general
anesthesia.
SHORT-TERM METABOLIC RESPONSES
METABOLIC EVENTS OCCURRING DURING NEURONAL ACTIVATION
Neuronal activation commonly is evoked during sensory or cogni-
tive stimulation or motor tasks. The stimulation activates neurons
in brain regions which respond to the intense incoming synaptic
input, resulting typically in ﬁring a sequence of action potentials.
Moreover, intermittent periods of increased neuronal activity also
can occur during the rapid-eye-movement (REM) stage of sleep,
which is associated with dream formation and consolidation of
learning and memory. Neuronal activation can also be evoked
in in vitro preparations, by a short train of electrical stimulation
pulses to excite axons and presynaptic terminals, resulting in post-
synaptic action potentials and often a compound evoked potential
response representing a combination of synaptic potentials and
actionpotentials (Galefﬁ et al., 2007,2011). The timing anddensity
of such stimulation can be varied but commonly the duration is
5–30 s, to temporarily“activate”neurons with an intense incoming
synaptic input. The energy demands associated with the neuronal
activity result in a cascade of metabolic events which can be mea-
sured in a number of different ways depending on the preparation
and the technique, shown on a timeline in Figure 1 (in vitro) and
Figure 2 (in vivo). Common measurements shown include extra-
cellular K+, Ca2+, oxygen, as well as metabolic imaging, such as
NADH or FAD.
For example, trigeminal nerve or whisker stimulation increases
glucosemetabolism in the thalamus and brain stem (Ciricillo et al.,
1994) based on the 2-deoxy-glucose imaging method (the ani-
mal equivalent to human FDG PET). Similarly, classical functional
imaging studies have reported an increase in blood ﬂow and in the
metabolic rate for oxygen and glucose during a sensory, motor,
or cognitive simulation after subtraction of baseline activity.
However, during sensory stimulation, measurements of glucose
and oxygen uptake using PET in human subjects have revealed
greater glucose consumption compared to oxygen (Fox et al.,
1988). Human detection methods (i.e., fMRI and PET) are some-
times insensitive to early events following neuronal activation due
to the small areas involved and rapid time course. During the ﬁrst
few seconds (i.e., up to 10 s) intracellular Na+ and Ca2+ starts to
build up and K+ is released from neurons whereas mitochondr-
ial intermediates are rapidly oxidized (together with oxygen) for
ATP generation, as noted in Figure 1. Real-time imaging methods
are more sensitive to these early changes but typically are more
invasive in nature.
For example, activity-dependent changes in NADH/NAD+
redox state can be monitored with real-time ﬂuorescence imag-
ing of NADH in vivo as well as in vitro. Physiological stimulation
leads to an NADH ﬂuorescence decrease in well-oxygenated tissue
(in vitro and in vivo), followed by either recovery to baseline or
an increase (i.e., overshoot) above baseline (Rosenthal and Jobsis,
1971; Lothman et al., 1975; Schuchmann et al., 2001; Shuttleworth
et al., 2003). Inﬂux of glucose and lactate to neurons results in
a transient decrease in lactate and glucose concentration in the
extracellular space (ECS; Hu and Wilson, 1997a,b). Perfusion of
the brain also depends on the tight coupling between O2 supply
and metabolic demand; stimulation of neurons results in a tran-
sient drop in O2 concentration due to increased oxidative phos-
phorylation (Foster et al., 2005), which stimulates a series of reac-
tions to increase cerebral blood ﬂow and match demand. Increases
in intracellular and mitochondrial Ca2+ also can enhance enzy-
matic activity within the tricarboxylic acid (TCA) cycle along with
release of oxygen free radicals and reactive oxygen species (ROS;
Duchen, 1992; Keelan et al., 1999; Kovacs et al., 2001; Schuchmann
et al., 2001). Tissue oxygen measurements with NADH imag-
ing during prolonged stimulation in vitro also revealed persistent
NADH oxidation and O2 utilization with continued metabolic
demand (Galefﬁ et al., 2011).
RECOVERY AFTER NEURONAL ACTIVATION
During recovery neuronal activity is decreasing to baseline but
metabolic needs can persist as well as delayed enhancement of
blood ﬂow. For example, NADH remains elevated temporarily
(Foster et al., 2005; Galefﬁ et al., 2011) due to persistent TCA cycle
dehydrogenase activity (Denton, 2009) and lactate uptake, extra-
cellular lactate rises as astrocytic metabolism continues, and local
bloodﬂow stays elevated,while short-term intermediatemolecules
within themitochondria are repleted, as noted in Figure 1. Eventu-
ally, neuronal activation winds down, leading to O2 consumption
trending down to basal levels as metabolism wanes, restoration
of membrane potentials by pumps, stabilization of NADH and
other mitochondrial intermediates once replenished, and ﬁnally
decreases in local blood ﬂow to control levels. Eventually NADH
levels recover back to baseline levels (Rosenthal and Jobsis, 1971;
Lothman et al., 1975; Schuchmann et al., 2001; Shuttleworth et al.,
2003).
CELLULAR LOCALIZATION OF ENERGY UTILIZATION AFTER NEURONAL
ACTIVATION – NEURONS VS ASTROCYTES?
Synaptic activity stimulates glucose uptake and glucose utiliza-
tion by both neurons and astrocytes (Sokoloff, 1999; Chih and
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FIGURE 1 |This series of traces illustrates the response to a 10–25
short stimulus train applied to the stratum radiatum of the CA1
region of an in vitro hippocampal tissue slice, and the physiological
responses which can be measured in real-time during this stimulus
train.These reconﬁgured traces have been redrawn from primary sources
to be on the same time scale (shown as 120 s below). Measured
responses include extracellular K+ and Ca2+ (Benninger et al., 1980) and
NADH imaging and tissue PO2 (Galefﬁ et al., 2007). Predicted in vitro
tissue slice responses are shown below with blue shading, with lactate
and glucose extrapolated from in vivo measurements performed by Hu
andWilson (1997a,b). Note that extracellular K+ rises during the train and
Ca2+ decreases, due to K+ release from neurons and Ca2+ uptake into
neurons. NADH shows both an oxidative phase (i.e., a decrease) and a
reduction phase (i.e., an increase), whereas in tissue slices the tissue
oxygen can only decrease from the baseline level. Extracellular glucose
can likewise only decrease, whereas lactate synthesis (stimulated by the
train) results in an initial dip (due to demand) but a subsequent elevation,
as lactate is further extruded from astrocytes.
Roberts, 2003). Cellular and tissue studies show that neurons likely
use a combination of extracellular lactate (derived from astrocytic
glycolysis) and glucose (Figure 3) as their energy substrates (Gal-
efﬁ et al., 2007). In vivo data reveals that there is a prevalence of
glycolysis over oxidative phosphorylation during neuronal activa-
tion which results in increased lactate production, likely primarily
within astrocytes (Dienel and Hertz, 2001).
However, evidence supporting direct lactate utilization by neu-
rons continues to have skeptics (Korf, 2006), including data
linking glucose (but not lactate) utilization with NMDA-induced
neurotransmission (Bak et al., 2006, 2009). In contrast, there
is activity-dependent oxidation of lactate in vivo (Wyss et al.,
2011), whereas astrocytic-derived lactate is necessary to maintain
long-term potentiation (Suzuki et al., 2011).
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FIGURE 2 |This series of redrawn and rescaled traces show measured
responses in vivo from intact brain (though different structures),
where changes in cerebral blood flow can alter the basic responses to
a stimulation train.The upper K+ and NADH traces are in response to a
25-s stimulus train at 10Hz in the cortex (Lothman et al., 1975), showing a
consistent K+ elevation and an NADH oxidation (Turner et al., 2007). The
CBF and PO2 responses follow a 15-s stimulation train at 10Hz in the
cerebellum (Offenhauser et al., 2005). The glucose and lactate
measurements are redrawn from Hu andWilson (1997a,b). Note that the
oxygen response shows an initial dip in the activated region then an
elevation as the enhanced cerebral blood ﬂow response occurs. There is
an initial decrease and a delayed enhancement in both cerebral lactate
(due to astrocytic extrusion) and glucose (due to enhanced transport into
the brain) as measured extracellularly.
In astrocytes, the presence of extracellular glutamate following
synaptic release induces rapid glutamate uptake [through gluta-
mate transporters (GLTs)] associated with Na+ inﬂux (Figure 3).
Uptake of glutamate and its conversion to glutamine and
subsequent recycling back to neurons requires energy provided
by glycolysis within astrocytes (Pellerin and Magistretti, 1996,
1997). In addition, de novo synthesis of glutamate from glu-
cose in astrocytes also requires ATP, through the TCA cycle
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FIGURE 3 | Regulation of synaptic function and cerebral blood flow:
modified schematic diagram (Attwell et al., 2010; Kapogiannis and
Mattson, 2011) showing the multiple interactions between an astrocyte,
neurons, and a blood vessel.The various functions depicted show
presynaptic release, glutamate receptor binding and handling, various energy
transport functions between blood vessels, the astrocyte and neurons,
vasoconstriction and vasodilation pathways, and extracellular molecules.
Abbreviations: RYR, ryanodine receptor; ER, endoplasmic reticulum; Glu,
glutamate; Gln, glutamine; IP3R, Inositol 3 phosphate receptor; Lac, lactate;
Glc, glucose; Pyr, pyruvate; TCA, Tricaboxylic acid cycle; ATP, adenosine 5’- tri
phosphate; Ach, acetyl choline; NE, norepinephrine; No, nitric oxide; Ad1,
adenosine receptor 1; Ad2, adenosine receptor 2; mGluR, metabotropic
glutamate receptor; NMDAR, N-methyl-D-aspartic acid receptor; AMPAR,
2-amino-3-(5-methyl-3-oxo-1;2- oxazol-4-yl)propanoic acid receptor; nNOS,
neuronal nitric oxide synthase; eNOS, endothelial nitric oxide synthase EET,
epoxyeicosatrienoic acids; AA, arachidonic acid; PGE2, prostaglandin 2;
20-HETE, 20-hydroxy arachidonic acid; PLA2, phospholipase A2; cGMP,cyclic
guanosine monophosphate; P2X; purinergicreceptor P2X; P2Y, purinergic
receptor P2Y; PLC, phospholipase C; AQP4, aquaporin-4; VDCC, voltage
dependent calcium channel; LTCC, L-type calcium channel.
intermediate α-keto-glutarate. The summary view at this time
is that glucose can be metabolized by both neurons and astro-
cytes, but neurons utilize a large proportion of extracellular
lactate for oxidative metabolism (perhaps greater than 50%,
drawn from a large extracellular pool of lactate generated
by astrocytes) and the balance from glucose (Zielke et al.,
2007).
DIFFERENCES IN SUBSTRATE DELIVERY IN VIVO VS IN VITRO SLICE
TISSUE PREPARATIONS
The large difference between the in vivo condition and in vitro
slice preparations is oxygen and glucose delivery, which occurs
via diffusion from tissue borders in vitro and through an exten-
sive vessel and capillary network in vivo (Turner et al., 2007).
Since there is no secondary blood ﬂow response in vitro, then
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the tissue levels of oxygen (Galefﬁ et al., 2007, 2011) and glu-
cose can only dip to lowered levels and recover in response to
the enhanced metabolic demand. In contrast to in vivo conditions
where hemoglobin can possess high oxygen saturation and con-
tent at low PO2 tensions, in in vitro preparations a high oxygen
tension is needed to maintain tissue oxygen levels, since oxygen
content and ﬂux through the tissue are very low with diffusion
alone, particularly at the long distances required to maintain slices
(i.e., up to 400–500μm depth). As a comparison, the oxygen dip
following signiﬁcant in vivo cortical activation may be∼5–10mm
Hg O2 (Thompson et al., 2003) whereas similar activation in a
tissue slice can lead to ∼180mm Hg O2 change (Galefﬁ et al.,
2011). This large difference in oxygen carrying capacity or content
can lead to considerable confusion about what may be a “sufﬁ-
cient” level of oxygen in tissue slices (i.e., Gordon et al., 2008);
clearly, the nature of the tissue slice preparation and the degree
of neuronal activation and metabolic demand may help clarify
the levels of oxygen required in the tissue bath, which should give
rise to values greater than 10–15mm Hg in the center of a slice
even with signiﬁcant metabolic demand. Our experience is that
relatively normal neuronal function requires at least 50% ambi-
ent oxygen levels (i.e.,>350mm Hg) to maintain even low levels
in the middle of slices during metabolic demand (Galefﬁ et al.,
2011).
CEREBRAL BLOOD FLOW
Stimulation of local neuronal activity increases local blood ﬂow
through a variety of neuronal and astrocytic mechanisms (Koehler
et al., 2009; Paulson et al., 2009). Metabolic signals derived
from both neurons and astrocytes can modulate both blood
ﬂow and substrate availability (Furchgott and Zawadzki, 1980;
Gordon et al., 2008). For example, NO generated by neurons
leads to vessel dilation and acetylcholine action on muscarinic
receptors of the endothelial cells can cause relaxation of vascu-
lar smooth muscle. Bradykinin is also an important vasodila-
tor, known to induce KCa channel activation in endothelial cells
through the generation of ROS (Nelson and Quayle, 1995; Sobey
et al., 1997). Glutamate also has a major role in regulating blood
ﬂow by increased NO generation from neurons and arachidonic
acid derived from astrocytes (Gordon et al., 2008). In astro-
cytes Ca2+ also activates phospholipase A2 and increases the
production of arachidonic acid metabolites (Figure 3), such as
prostaglandins and epoxyeicosatrienoic acids, which dilate nearby
arterioles (Iadecola and Nedergaard, 2007; Koehler et al., 2009).
Prostaglandins binding to the EP4 PG receptors activate pro-
tein kinase A by cAMP and thus decrease phosphorylation of
myosin chains; EETs inhibit the receptors for thromboxane thereby
inhibiting vasoconstriction. Adenosine, a metabolite of ATP, also
modulates blood ﬂow, through A2A receptors localized on arte-
rioles (Gordon et al., 2008). Rapid glycolysis during neuronal
activation increases the conversion of pyruvate to lactate and an
increased NADH/NAD+ ratio, which in turn increases cerebral
blood ﬂow (Ido et al., 2004; Pellerin et al., 2007; Gordon et al.,
2008). A number of these mechanisms are directly in response
to neuronal and astrocytic activation, linking neuronal activity to
metabolic demand and supply in a number of ways (Figure 2).
Measurements in vivo in intact preparations include K+, NADH,
cerebral blood ﬂow,oxygen, as well as lactate and glucose, as shown
in Figure 2.
HEAT PRODUCTION
Direct heat emission can reveal the source(s) of ongoing metabo-
lism (both through ATP hydrolysis as well as mitochondrial heat
release) at a cellular and circuit level, as well as the efﬁciency of
metabolism [i.e., the coupling of mitochondrial energy with ATP
production or heat release (LaManna et al., 1980, 1989; Yablonskiy
et al., 2000; Trubel et al., 2005)]. Maintenance of mitochondrial
membrane potential for ATP generation releases ∼33% of total
energy as heat, but ATP hydrolysis also leads to heat production,
whereas there is minimal heat production by anaerobic glycolysis
(LaManna et al., 1980; Yablonskiy et al., 2000). The considerable
resulting heat production is rapidly diffused into surrounding tis-
sue, but since the brain resides in a closed space the heat must
be dissipated by a large cerebrovascular response (LaManna et al.,
1989; Trubel et al., 2005). In most instances, the cerebrovascular
(dilation) response to neuronal metabolism is far out of propor-
tion to the substrate supply need, suggesting that a secondary
function of the vascular response is heat shunting (Sukstanskii
andYablonskiy, 2006). In spite of the considerable heat dissipation
through the vascular systemneuronal activation can still lead to up
to 0.5˚C temperature elevation in a local region,whereas spreading
depression, seizures and recovery from ischemia can generate up
to 1.0˚C in intact cortex (LaManna et al., 1980, 1989). Direct heat
emission imaging with specialized infrared cameras may resolve
the efﬁciency of metabolism since uncoupling of ATP genera-
tion from mitochondrial membrane potential releases nearly all
of metabolism as heat.
CHANGES IN EXTRACELLULAR SPACE
Both astrocytes and neurons swell with activation due to Na+ and
water entry, leading to shrinkage of the ECS (Bourke et al., 1980;
Fayuk et al., 2002). For example, the ECS of the mature optic
nerve and also hippocampus rapidly and reversibly decreases by
as much as 20% (Ransom et al., 1985; Fayuk et al., 2002). Intrinsic
optical signal (IOS) imaging and measurements also have revealed
spontaneous neuronal hyperactivity associated with ECS shrink-
age in vitro (Buchheim et al., 1999). This swelling is rapid and
reversible and is related to duration of the physiological stim-
uli (Dietzel et al., 1982) but also is associated with anoxia and
inﬂammation (Hochwald et al., 1981). The shrinkage of ECS in
central nervous system is also observed developmentally due to
activity-dependent changes in postnatal development (Bondar-
eff and Pysh, 1968; Van Harreveld et al., 1969; Connors et al.,
1982). Thus, ECS or IOS imaging may augment other methods of
following neuronal activation and metabolism.
SUMMARY
Following neuronal activation a complex sequence of responses
in neurons, astrocytes and blood vessels orchestrates enhanced
substrate supply and blood ﬂow to be able to maintain the
energy requirements for the activation regardless of duration. We
now summarize some of these critical intermediate signals and
how they function to preserve metabolic homeostasis within the
cerebral metabolic unit.
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FACTORS INVOLVED IN SHORT-TERM ENERGY
HOMEOSTASIS
CRITICAL INTERMEDIATE SIGNALS UNDERLYING NEURONAL–GLIAL
COMMUNICATION
There are a number of factors and signals responsible for homeo-
static maintenance of neuronal function and energy metabolism.
As soon as neuronal activity is stimulated neurons initially show
Na+ and Ca2+ inward currents and then subsequently release K+,
glutamate, NO, CO2, and H2O2 into the ECS; this increased neu-
ronal activity requires increased oxygen, lactate and glucose uptake
tomaintainmetabolic function. The neuronal uptake of metabolic
substrates and the release of secondary signals (i.e., K+, NO, and
glutamate in particular) can function as intermediate cues needed
for enhancement of metabolic substrate utilization. These cues
then are used as signals by astrocytes and blood vessels to enhance
blood ﬂow and substrate delivery, which are ampliﬁed into sec-
ondary signals, such as ATP release, to spread within astrocytic
networks. We will discuss these critical intermediate signals and
the astrocytic responses which occur for short-term maintenance
of metabolism.
Na+/K+ HOMEOSTASIS
Na+ entry via voltage-dependent channels and action potential
generation underlay the basic function of neurons for rapid com-
munication and information processing, with a large number of
K+-voltage channels needed to repolarize neurons at various time
intervals; thus, tight regulation of extracellular K+ is important for
maintaining neuronal activation through rapid membrane repo-
larization. Astrocytes maintain extracellular K+ homeostasis via
both passive and active mechanism of uptake through a variety of
voltage-dependent channels and transporters, which is then dissi-
pated back to the ECS, other astrocytes or blood vessels (Figure 3).
Membrane-bound Na+/K+ ATPase (Skou and Esmann, 1992) is
the key enzyme responsible for the maintenance of intracellular
ion homeostasis in both neurons and astrocytes (Walz and Hertz,
1982). Na+/K+ ATPase hydrolyzes ATP to ADP in the process
of extruding three Na+ against two K+ molecules; inhibition of
Na+/K+ ATPase results in amarked decrease in astrocyticmetabo-
lism. Thus, astrocytes may exert considerable energy for K+ extra-
cellular stabilization, which helps to maintain neuronal excitabil-
ity, and in turn K+ provides an immediate extracellular signal to
astrocytes demonstrating neuronal action potential ﬁring.
GLUTAMATE METABOLISM
Glutamate uptake into astrocytes via GLT following synaptic
release is another major signaling factor to astrocytes, reﬂecting
neuronal activation (Parpura et al., 1994; Anderson and Swan-
son, 2000; Auger and Attwell, 2000; Danbolt, 2001; Malarkey
and Parpura, 2008). Glutamate is the major excitatory neuro-
transmitter released throughout the brain, and glutamate action
is primarily terminated by glutamate uptake into astrocytes
via GLTs. Neurons express both ionotropic and metabotropic
glutamate receptors, including (NMDA N -methyl-d-aspartate),
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPA), and kainate subtypes (Figure 3). Astrocytes also express
metabotropic receptors (mGlur 1–8), which are a family of G
protein coupled receptors, mediating effects primarily through
second messengers. Astrocytes expresses mainly mGlur receptors
subtypes 2, 3, and 5: mGlur 5 is coupled to phosphoinositide (PI)
hydrolysis and can increase intracellular calcium, whereas mGlur
2 and 3 are negatively coupled to adenylate cyclase to inhibit cAMP
formation.
In addition to glutamate actions on these receptors, astro-
cytes also uptake glutamate through glutamate transport protein-
mediated endocytosis and then astrocytes recycle the glutamate
back to neurons for further use by synthesis of glutamine (via glu-
tamine synthetase, exclusively in astrocytes)with secondary release
for neuronal uptake and repackaging of glutamate. This recycling
creates a glutamate–glutamine cycle (Figure 3) occurring between
neurons and astrocytes (Van den Berg et al., 1969; Balazs et al.,
1970;Van den Berg and Garﬁnkel, 1971; Norenberg and Martinez-
Hernandez, 1979). The vesicular uptake of glutamate requires
glutamate transport protein and vacuolar-type H+-ATPase,which
couples ATP hydrolysis and glutamate transport. (Naito and Ueda,
1983; Ozkan and Ueda, 1998) and which also make the interior of
the vesicle acidic. Glutamine uptake into neurons increases dur-
ing hypoglycemia since glutamine can also be oxidized for energy
production in low glucose conditions (Amaral et al., 2011).
Most of the glutamate taken up by the astrocytes is eventu-
ally converted to glutamine for extrusion and recycling back to
neurons, via glutamine synthase. However, oxidation of glutamate
can be increased up to 45% when the extracellular glutamate con-
centration increases beyond 100 μM (McKenna et al., 1996a,b).
Exposure of cultured astrocytes to glutamate in glucose can also
stimulate oxidative phosphorylation, reducing glucose utilization
(Qu et al., 2001; Dienel and Cruz, 2006). Oxidation of gluta-
mate provides more ATP than that generated from lactate, and
spares the need for glucose utilization. Oxidation of glutamate
in the cell can also generate pyruvate and lactate (Moreadith and
Lehninger, 1984).Under steady state basalmetabolism the levels of
TCA derived intermediates are stable but the rate of degradation
increases with neuronal activation (Gruetter et al., 2001; Sibson
et al., 2001). During activation oxidation of TCA cycle derived
amino acids, such as glutamate, GABA, and aspartate can provide
a signiﬁcant energy source. Glutamate may also be recycled in
the form of lactate and alanine or other TCA cycle intermediates
(Dringen et al., 1993; Westergaard et al., 1995). These intermedi-
atesmay be important since neurons lack the capacity to synthesize
TCA cycle constituents de novo due to absence of pyruvate car-
boxylase (Yu et al., 1983; Shank et al., 1985; Cesar and Hamprecht,
1995).
Ca2+ HOMEOSTASIS
The extracellular concentration of Ca2+ is typically ∼1.2mM,
compared to the intracellular concentration of 100 nM (Somjen,
2002). This large transmembrane gradient of Ca2+ can create a
high inward ﬂux and incoming Ca2+ ions can make a large impact
on intracellular Ca2+ levels. The reverse transport of calcium
across the membrane back into the ECS is maintained by energy
dependent extrusion. For example, inwardCa2+ ﬂux (Figure 3) via
voltage sensitive calcium channels (L-type) activated by elevated
K+ stimulates both the Na+, K+, Cl− co-transporter (Su et al.,
2000) and also oxidative metabolism (Hertz and Dienel, 2002).
These transporters are also regulated by intracellular messengers
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such as cAMP, cGMP, Ca2+/calmodulin and also by cell shrinkage
or swelling (Jensen et al., 1993; O’Neill, 1999). The degree of cal-
cium inﬂux is dependent on the frequency of stimulation, particu-
larly above 10Hz. Increased Ca2+ inﬂux promote a large number
of reactions formetabolic function, particularlymodulation of the
rate of the TCA cycle for NADH/FAD production and ATP gener-
ation through direct inﬂuence on the dehydrogenase reactions.
Tight buffering of cytoplasmic Ca2+ is maintained by Ca2+
extrusion, sequestration with Ca2+ binding molecules, and
uptake into organelles including endoplasmic reticulum (ER)
and mitochondria. Each molecule of Ca2+ transported either
into endoplasmic reticulum or out of the plasma membrane
requires one molecule of ATP, through Ca2+ ATPase activity or
the Na+/Ca2+ exchanger. Inﬂux of Ca2+ is important for initia-
tion of long-term neuronal signaling (i.e., long-term potentiation)
and also for activation of TCA cycle enzymes and mitochondr-
ial oxidative phosphorylation. Buffering of mitochondrial Ca2+
is important to prevent toxic effects exerted by increased ROS
generation and loss of signaling efﬁcacy. However, extrusion of
Ca2+ from mitochondria occurs at time points when Ca2+ lev-
els in the cytosol return to baseline and when ATP demand and
O2 consumption are low, through either a mitochondrial Ca2+
proton exchanger or the mitochondrial permeability transition
pore (MTP). The kinetics of transport for these exchangers is low,
which can enhance Ca2+ overload in mitochondria. During neu-
ronal activation astrocytes show elevation of intracellular Ca2+,
which may be spontaneous or triggered by ATP released extra-
cellularly (Charles et al., 1991). In neurons Ca2+ inﬂux occurs
at synapses via NMDA receptors and L-type calcium channels
(LTCCs). CaV1.2 is a widely expressed LTCC in the brain, local-
ized mainly at dendritic shafts and spines (Hell et al., 1993; Clark
et al., 2003; Obermair et al., 2004; Schlick et al., 2010); this LTCC
can be internalized through tumor suppressor eIF3e mediated cal-
cium and dynamin-dependent endocytosis (Green et al., 2007; Di
Biase et al., 2011).
ATP SIGNALING
Both neurons and astrocytes can release ATP during basal meta-
bolic activity and during neuronal activation. ATP acts as a neuro-
transmitter by binding to purinergic receptors (Burnstock, 1999;
Fields and Stevens, 2000). However, ATP release from astrocytes
is likely the main source of extracellular ATP (Butt, 2011) and is
mediated by exocytosis (Pangrsic et al., 2007). ATP can also trig-
ger a rise in intracellular calcium within astrocytes, particularly
as a delayed Ca2+ wave (Figure 3). This action is mediated by
an elevation in nicotinic acid-adenine dinucleotide phosphate by
ATP (Barceló-Torns et al., 2011). Purinergic receptors are either
ionotropic (P2X) or metabotropic (P2Y). P2X receptors consists
of seven transmembrane subunits (P2× 1–P2× 7) involved in fast
synaptic transmission (Bardoni et al., 1997). Metabotropic recep-
tors (P2Y1,Y2,Y4,Y6,Y11) are abundant throughout the nervous
system (Abbracchio and Burnstock, 1994; Cook et al., 1997) and
are coupled with Gq/G11 proteins which activate phospholipase
c/inositol triphosphate pathways to increase intracellular Ca2+
(Kastritsis et al., 1992). In contrast, P2Y receptors are linked to
GI/0 proteins.
Quantal release of ATP from neuronal synaptic terminals has
been characterized by the analysis of P2X receptor-mediated
evoked and spontaneous miniature excitatory postsynaptic cur-
rents (mEPSCs) in hippocampal neurons (Pankratov et al., 2006).
P2X mediated mEPSCs are different from glutamate mediated
mEPSCs in terms of amplitude and kinetics. It has been spec-
ulated that ATP is released either from a separate pool of vesi-
cles (White and MacDonald, 1990) or vesicles associated with
acetylcholine, GABA, or glutamate (William, 2003; Pankratov
et al., 2006). Astrocytes also release ATP from vesicles containing
SNARE complexes; the release of ATP is suppressed in transgenic
mice expressing a dominant negative SNARE domain (Pascual
et al., 2005). ATP is also a potent vasoconstrictor and astro-
cytes demonstrate secondary Ca2+ waves through highly enriched
purinergic receptors (P2Y2 and 4; Butt, 2011). However, ATP
as a vasoconstrictor is opposed by adenosine, a metabolite of
ATP, which acts as a potent vasodilator; the relative balance of
these two metabolites at the astrocytic-vascular interface plays
an important role in neurovascular coupling mechanisms (Butt,
2011).
ADENOSINE
Adenosine, a metabolite of ATP, exerts potent vasodilation effects
and inhibits neuronal transmission via AD1 receptors (Figure 3);
this can result in inhibition of glutamate release at presynap-
tic terminals of Schaffer collaterals in the CA1 hippocampus
and reduce the release of glutamate from these ﬁbers (Fowler,
1992; Lupica et al., 1992; Zhu and Krnjevic, 1993; Butt, 2011).
Adenosine can also enhance the release of several neurotrans-
mitters, such as acetylcholine, glutamate, and noradrenaline, via
AD2 receptors (Sebastiao and Ribeiro, 1996). Extracellular adeno-
sine formation from ATP/ADP/AMP depends upon the activity of
ecto-5′-nucleotidase and the overall levels of energy metabolism
and ATP levels. Extracellular concentration of adenosine is main-
tained by speciﬁc nucleoside transporters present in both neurons
and astrocytes and by its conversion to inosine. For example,
insulin-induced hypoglycemia increases extracellular adenosine
levels and depresses evoked synaptic potentials (Chapman et al.,
1981; Fan et al., 1988).
Addition of alternative substrates, such as lactate, during glu-
cose deprivation can maintain ATP levels and signiﬁcantly reduce
adenosine levels, leading to improved neuronal function (Fowler,
1993). Addition of AD1 receptor antagonists also can extend
synaptic activity for a limited period of time in low glucose
conditions, suggesting that adenosine levels rise before complete
energy failure occurs (Shetty et al., 2012). Adenosine can also
block voltage-dependent calcium channels (Phillis and Wu, 1981;
Scholz and Miller, 1991; Bennett and Ho, 1992; Mogul et al.,
1993) and thereby inhibits presynaptic calcium ﬂuxes. Differential
effects of adenosine on calcium channels depends on adenosine
receptor subtype activation and has signiﬁcant implications for
neuronal excitability (Mogul et al., 1993). Adenosine also acti-
vates presynaptic potassium channels and can attenuate evoked
neurotransmitter release by hyperpolarizing the presynapticmem-
brane during aglycemia (Bachelard et al., 1984; Knopfel et al.,
1990).
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GLYCOGEN UTILIZATION AND SYNAPTIC ACTIVITY
Though brain utilizes glucose for its energy substrate there is also
the capacity to store glucose in the form of glycogen. Although the
enzyme for glycogen formation, glycogen synthase, is present in
both astrocytes and neurons glycogen storage capability and glyco-
gen degrading enzymes are localized only in astrocytes (Vilchez
et al., 2007). However, innate glycogen levels in the brain appear
small compared to liver and muscle glycogen content (3–12μmol
glycosyl units/g; Cataldo and Broadwell, 1986; Cruz and Dienel,
2002; Choi and Gruetter, 2003; Suh et al., 2007). In certain con-
ditions glycogen levels can be augmented; for example, between
periods of intermittent hypoglycemia glycogen levels can increase
above normal levels (termed supercompensation). The ability of
brain tissue to accumulate extra glycogen has been also demon-
strated in brain slices following supplementation with extra glu-
cose, pyruvate, or lactate (Shetty et al., 2012). Because glycogen
is stored only in astrocytes, its utilization by neurons (likely
as extruded lactate) reveals highly coordinated energy metabo-
lism interactions between astrocytes and neurons (Suzuki et al.,
2011).
Astrocytic stored glycogen can be rapidly converted directly
into pyruvate via glycolysis or perhaps glucose (Ghosh et al.,
2005). Glycogen storage is advantageous in some ways since no
further ATP is required to initiate metabolism, unlike glucose
and fatty acids (Hertz et al., 2007). Glycogen-derived lactate is
likely released into the ECS (Figure 3) and taken up by neu-
rons for energy, particularly in low glucose conditions where
glycogenolysis is initiated (Dringen et al., 1993; Pellerin and Mag-
istretti, 1994; Magistretti and Pellerin, 1999; Brown et al., 2004).
In contrast, the utilization of glycogen during euglycemic con-
ditions is controversial. Inhibition of glycogen breakdown by
1,4-dideaxy-1, 4-imino-d-arabinitol (DAB; glycogen phosphory-
lase inhibitor) did not suppress ongoing neuronal activity during
euglycemic conditions (Shetty et al., 2012). In contrast, blocking
glycogen metabolism in vivo with DAB may impair hippocam-
pal memory formation (Suzuki et al., 2011). Glycogen may also
be utilized for glutamate and glutamine synthesis (Gibbs et al.,
2006, 2007; Sickmann et al., 2009). Glycogen-derived energy is
also involved in the uptake of glutamate, since inhibition of glyco-
gen breakdown impairs the uptake of the glutamate analog d-
[3H]aspartate irrespective of the presence of glucose in cultured
astrocytes (Sickmann et al., 2009). Glycogenolysis can be stimu-
lated directly by low glucose levels, norepinephrine, and vasoac-
tive intestinal peptide (VIP) (Magistretti et al., 1998; Magistretti,
2006).
SUMMARY
Short-term regulation of the metabolic unit occurs through tight
regulation of these multiple local factors, acting between neu-
rons, astrocytes and blood vessels, on the time scale of seconds
to minutes. Some factors, such as glycogen, can also potentially
help prevent substrate starvation over a period of up to an hour.
However, during long-term issues such as development and aging
there are a number of other cues needed to maintain homeosta-
sis, beyond these factors implicated in short-term regulation of
metabolism.
LONG-TERM REGULATION OF CNS ENERGY METABOLISM
Complex neuronal networks regulate long-term energy homeosta-
sis, using a variety of peripheral and brain derived hormones to
regulate appetite and body weight. For example, brain function
responds to changes in insulin, leptins, orexin, neuropeptide Y,
propiomelanocortin, epinephrine, norepinephrine, glucagon, glu-
tamate, and a wide variety of other systemic stimuli and regulatory
molecules, some of which can act as growth factors for long-term
support of the brain. We discuss a few of these factors relevant to
energy homeostasis in the brain.
LEPTIN
Leptin and orexin are involved in long-term weight regulation.
Leptin functions to regulate body fat, but leptin receptors are
widely expressed throughout the CNS, particularly in hippocam-
pus, cerebellum, brain stem and amygdala (Elmquist et al., 1998;
Hakansson et al., 1998; Harvey, 2003), suggesting that leptin
may be involved in other roles in CNS function. Leptin can
increase memory formation and hippocampal synaptic plasticity
through facilitation of Ca2+ inﬂux via NMDA receptors (Shan-
ley et al., 2001), functioning by phosphorylation of MAPK, Src,
or PI3 Kinase mediated pathways. However, incubation of leptin
with brain slices at resting conditions without glutamate failed
to increase Ca2+ concentrations. Leptin can also inhibit mTOR
and can function as an antiepileptogenic hormone. Leptin also
activates AMP-activated protein kinase (AMPK) and Silent infor-
mation regulator proteins (Sirtuins) in neurons and is neuropro-
tective (Greco et al., 2011). Sirtuins are histone deacetylases and
are dependent on nicotinamide adenine dinucleotide (NAD+)
and upregulation of proteins required for energy metabolism and
survival (Zhang et al., 2011).
INSULIN
Thehormone insulin,whichhas the ability to activate cell signaling
pathways similar to leptin and can function as a neurotrophic fac-
tor, facilitates NMDA receptor-mediated responses. Insulin may
also decrease Alzheimer pathology by regulating tau phosphoryla-
tion and by inhibiting GSK-3 function (Greco et al., 2009, 2011).
Neurons can secrete insulin in a calcium-dependent manner when
depolarized but this appears to be more of a neurotrophic role
rather than associatedwith energy homeostasis. Insulin can inhibit
neuronal activity by activating theCa2+ activated potassium chan-
nel via mitogen activated protein kinase dependent process. There
are now trials beginning administering intranasal insulin for pos-
sible treatment of Alzheimer’s disease, since this may be a less
invasive method of delivery.
STARVATION AND KETOSIS RESPONSES
During severe fasting or with rigorous exercise circulating blood
glucose levels fall, leading to initiation of regulatory responses
by the liver, particularly increased glucose synthesis and glycogen
degradation (Amiel, 1997). Activation of sympathetic neurons,
stimulation of adrenalin, cortisol, and enhanced growth hormone
secretion all favor increased blood glucose but through different
mechanisms, after a more prolonged period of fasting (i.e., 8–
12 h); growth hormone in particular can liberate fat from lipid
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stores as ketone bodies, beta-hydroxybutyrate and acetoacetate.
Brain can utilize ketone bodies as a alternative energy source
during starvation or hypoglycemia. Because of their permeability
through the bloodbrain barrier viamonocarboxylate transporters,
these compounds do have ready access to the nervous system and
are easily metabolized by the brain (Puchowicz et al., 2007). Beta-
hydroxybutyrate, the major ketone body in the circulation, can
preserve ATP levels in the brain during low glucose conditions and
early development. The rate of utilization of beta-hydroxybutyrate
is very high during brain development, particularly during post-
natal suckling in mammals, but reduced as animals wean from
breast milk after P14 in rats (Izumi et al., 1998). Thus, during star-
vation a long-term series of changes occur in metabolism to adapt
to different energy sources, and particularly to utilize internal fat
and eventually protein for energy substrates.
ROLE OF SIRTUINS
Sirtuins (Sirt) are a family of nicotinamide adenine nucleotide
(NAD) dependent deacetylases, which are implicated in energy
metabolism and life span (Michan and Sinclair, 2007;Yu andAuw-
erx, 2009). Among the known Sirt isoforms (Sirt1–7), Sirt3 has
been identiﬁed as a stress responsive deacetylase recently shown
to have a role in protecting cells under stress conditions (Sun-
daresan et al., 2008; Kim et al., 2011). Sirt3 was shown to regulate
the activity of acetyl-CoA synthetase 2 (AceCS2), an important
mitochondrial enzyme involved in generating acetyl-CoA for the
TCA cycle. In these studies, Sirt3 knockout resulted in a marked
decrease of basal ATP level in vivo (Hirschey et al., 2010, 2011b;
Shimazu et al., 2010). Overexpression of Sirt1 and the use of the
Sirt1 agonist, resveratrol, were neuroprotective against amyloid
beta toxicity by reducing microglial NF-kappaB signaling (Chen
et al., 2005). Mitochondrial protein acetylation is markedly ele-
vated in Sirt3(−/−) tissues (Ahn et al., 2008; Sundaresan et al.,
2008; Huang et al., 2010). NAD-dependent deacetylation regu-
lates energy homeostasis and the absence of the deacetylase leads
to a marked reduction in ATP. Complex I activity can be regulated
by acetylation and deacetylation, a posttranslational modiﬁca-
tion, and Sirt3 also deacetylates GDH and AceCS2 (Hallows et al.,
2006; Hirschey et al., 2011a). Sirt has been implicated in caloric
restriction as a treatment to enhance life span during aging as
well (Someya et al., 2010; Hallows et al., 2011; Shetty et al., 2011;
Zhang et al., 2011). This is one of several regulatory molecules
spanning the gap between nuclear regulation of metabolism and
actual metabolic processing.
PATHOLOGICAL CONDITIONS LEADING TO ENERGY CRISES
Inadequate supply of oxygen and glucose to the brain can lead to
impaired brain function, and if sustained, to permanent cell loss
and damage. The clinical conditions where this occurs are usually
termed stroke, which commonly arises from changes in blood ves-
sels, such as thrombosis or embolic reasons. Energy metabolism
deﬁcits during ischemia can inhibit Na+/K+ ATPase activity and
lead to increased ROS generation. Drugs that increase Na+/K+
ATPase activity have a positive effect on neuronal energy metabo-
lism during oxidative stress (Simao et al., 2011). During hypoxia,
decreased ATP content leads to rapid depression of the evoked
synaptic potentials (Lipton and Whittingham, 1979, 1982). The
brain can eventually adapt to these energy crises by increasing col-
lateral blood ﬂow and eventually demarcating regions of the brain
into areas with partial or intact neuronal function, separating out
regions of permanent damage.
CONCLUSION
Energy homeostasis is an ongoing process under baseline con-
scious conditions, during and after brief periods of neuronal
activation with accompanying changes in metabolic demand and
supply, and also over long-term periods. There are multiple links
between neurons, astrocytes, and blood vessels to maintain home-
ostasis during a wide range of energy demand and supply con-
ditions in the nervous system. Some of these links can now be
directlymeasured by in vivo or in vitro imaging techniques, includ-
ing PET, fMRI, intrinsic ﬂuorescent imaging (such as NADH or
FAD), direct imaging of ion ﬂuxes (i.e., Na+, Ca2+, Cl−), ECS
imaging (with IOS), blood ﬂow and oxygen or nitric oxide tissue
measurements, and possibly direct heat emission imaging, taking
advantage of the large heat signature released by metabolism.
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